IL-33 also has a role in the anti-tumour response to melanoma by not only increasing the secretion of INFγ and granzyme B from CD8+ T and NK cells as well as proliferation of CD4+ T cells [105,106] but also reducing the differentiation of PMN-MDSCs from bone marrow cells [106]. This evidence concerns the gene CD8A and melanoma.